Genetic Signatures is a specialist molecular diagnostics (MDx) company focused on the development and commercialisation of its proprietary platform technology, 3base. Genetic Signatures has released a suite of real-time PCR based products for the routine detection of infectious diseases under the EasyScreen brand . This proprietary MDx technology provides hospitals and pathology laboratories with the ability to screen for a wide array of infectious pathogens with a high degree of specificity in a rapid throughput (time to result) environment.

Genetic Signatures’ executive management team combines the scientific skills of the technology developers with the business acumen of industry veterans experienced in critical expansion markets.

Production Facility

Our customers` continuous product supply requirements are consistently met due to enhanced efficiencies in production and automation processes, as well as the maintenance of close partnerships with reliable suppliers of high quality reagents and consumables.

The Production Facility produce and assemble the reagents that comprise our EasyScreen™ Sample Processing Kits and EasyScreen™ Detection Kits. They also produce our proprietary 3base™ Conversion Reagent, which is part of the sample processing protocol. Our Production team works closely with our Regulatory and Quality Assurance teams to ensure the performance of our products meet the regulatory requirements of different regions. This includes our successful relationships with international warehousing and logistics companies for fast and reliable global shipment of our products.

Biotech Predictions 2022 - Video